minor reference to cyc.
this article demonstrates the due diligence KPC complete before committing to a stock .
search: a de-risked biotech with 4x upside
- Forums
- ASX - By Stock
- CYC
- News: CYC Cyclopharm Posts FY Sales Revenue Of A$17.70 Million
News: CYC Cyclopharm Posts FY Sales Revenue Of A$17.70 Million, page-2
Featured News
Add CYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.75 |
Change
0.110(6.71%) |
Mkt cap ! $194.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.75 | $1.64 | $72.69K | 42.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4317 | $1.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.75 | 12891 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4317 | 1.720 |
2 | 1900 | 1.710 |
1 | 2000 | 1.660 |
1 | 9060 | 1.605 |
2 | 1110 | 1.535 |
Price($) | Vol. | No. |
---|---|---|
1.750 | 12891 | 2 |
1.790 | 550 | 1 |
1.850 | 3482 | 1 |
1.970 | 2640 | 1 |
2.010 | 2521 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CYC (ASX) Chart |